EGFR and cancer: The mechanisms of cancer expansion via EVs are various and include immunosuppression, metabolic reprogramming, and the transfer of active oncogenes, e.g., EGFR, the mutant form of KRAS, and integrins into the cells of the target organ [16,17,18,19].